Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorothea Orth

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Plos One|November 10, 2012
N-chlorotaurine, a long-lived oxidant produced by human leukocytes, inactivates Shiga toxin of enterohemorrhagic Escherichia coliChristian Eitzinger, Silvia Ehrlenbach, Herbert Lindner, et al.
Infection and Immunity|July 21, 2010
EspP, a serine protease of enterohemorrhagic Escherichia coli, impairs complement activation by cleaving complement factors C3/C3b and C5Dorothea Orth, Silvia Ehrlenbach, Jens Brockmeyer, et al.
International Journal of Hygiene and Environmental Health|September 25, 2007
Prevalence of Shiga toxin-, intimin- and haemolysin genes in Escherichia coli isolates from drinking water supplies in a rural area of AustriaMilad Halabi, Dorothea Orth, Katharina Grif, et al.
Wiener Klinische Wochenschrift|April 25, 2012
Rapid detection of bloodstream pathogens by real-time PCR in patients with sepsisKatharina Grif, Manfred Fille, Reinhard Würzner, et al.
Molecular Immunology|December 10, 2013
Interaction of Shiga toxin 2 with complement regulators of the factor H protein familyKulwara Poolpol, Dorothea Orth-Höller, Cornelia Speth, et al.
Infection and Immunity|May 22, 2013
Shiga toxin 2 reduces complement inhibitor CD59 expression on human renal tubular epithelial and glomerular endothelial cellsSilvia Ehrlenbach, Alejandra Rosales, Wilfried Posch, et al.
Pediatric Nephrology (Berlin, Germany)|April 8, 2024
Outcome 10 years after Shiga toxin-producing E. coli (STEC)-associated hemolytic uremic syndrome: importance of long-term follow-upAlejandra Rosales, Sarah Kuppelwieser, Thomas Giner, et al.
Microbiologyopen|December 4, 2018
High percentage of microbial colonization of osteosynthesis material in clinically unremarkable patientsLudwig Knabl, Bettina Kuppelwieser, Astrid Mayr, et al.
Medizinische Genetik : Mitteilungsblatt Des Berufsverbandes Medizinische Genetik E.V|April 2, 2019
The genetics of atypical hemolytic uremic syndromeWouter J C Feitz, Nicole C A J van de Kar, Dorothea Orth-Höller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2012
Need for long-term follow-up in enterohemorrhagic Escherichia coli-associated hemolytic uremic syndrome due to late-emerging sequelaeAlejandra Rosales, Johannes Hofer, Lothar-Bernd Zimmerhackl, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Plos One|November 10, 2012
N-chlorotaurine, a long-lived oxidant produced by human leukocytes, inactivates Shiga toxin of enterohemorrhagic Escherichia coliChristian Eitzinger, Silvia Ehrlenbach, Herbert Lindner, et al.
Infection and Immunity|July 21, 2010
EspP, a serine protease of enterohemorrhagic Escherichia coli, impairs complement activation by cleaving complement factors C3/C3b and C5Dorothea Orth, Silvia Ehrlenbach, Jens Brockmeyer, et al.
International Journal of Hygiene and Environmental Health|September 25, 2007
Prevalence of Shiga toxin-, intimin- and haemolysin genes in Escherichia coli isolates from drinking water supplies in a rural area of AustriaMilad Halabi, Dorothea Orth, Katharina Grif, et al.
Wiener Klinische Wochenschrift|April 25, 2012
Rapid detection of bloodstream pathogens by real-time PCR in patients with sepsisKatharina Grif, Manfred Fille, Reinhard Würzner, et al.
Molecular Immunology|December 10, 2013
Interaction of Shiga toxin 2 with complement regulators of the factor H protein familyKulwara Poolpol, Dorothea Orth-Höller, Cornelia Speth, et al.
Infection and Immunity|May 22, 2013
Shiga toxin 2 reduces complement inhibitor CD59 expression on human renal tubular epithelial and glomerular endothelial cellsSilvia Ehrlenbach, Alejandra Rosales, Wilfried Posch, et al.
Pediatric Nephrology (Berlin, Germany)|April 8, 2024
Outcome 10 years after Shiga toxin-producing E. coli (STEC)-associated hemolytic uremic syndrome: importance of long-term follow-upAlejandra Rosales, Sarah Kuppelwieser, Thomas Giner, et al.
Microbiologyopen|December 4, 2018
High percentage of microbial colonization of osteosynthesis material in clinically unremarkable patientsLudwig Knabl, Bettina Kuppelwieser, Astrid Mayr, et al.
Medizinische Genetik : Mitteilungsblatt Des Berufsverbandes Medizinische Genetik E.V|April 2, 2019
The genetics of atypical hemolytic uremic syndromeWouter J C Feitz, Nicole C A J van de Kar, Dorothea Orth-Höller, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2012
Need for long-term follow-up in enterohemorrhagic Escherichia coli-associated hemolytic uremic syndrome due to late-emerging sequelaeAlejandra Rosales, Johannes Hofer, Lothar-Bernd Zimmerhackl, et al.
Pageof 8